When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CTDH - Cyclo Therapeutics slips after reporting preliminary Trappsol Cyclo data
Ctd Holdings Inc
Thinly traded nano cap Cyclo Therapeutics (OTCQB:CTDH-6.6%) announces topline results from 25 participants in two clinical trials, a Phase 1 and a Phase 1/2, assessing the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of two and three dose regimens, respectively, of Trappsol Cyclo (hydroxypropyl beta cyclodextrin) in patients with Niemann-Pick Disease Type C1 (NPC1), a rare inherited progressive neurodegenerative disorder caused by the body's inability to transport cholesterol and other lipids inside cells.
More news on: Cyclo Therapeutics, Inc.A, Healthcare stocks news, Stocks on the move,